ILMN Stock Analysis: Buy, Sell, or Hold?
ILMN - Illumina Inc
$170.93
8.38 (5.16%)
▲
5d:
+13.82%
30d:
+22.64%
90d:
+32.53%
HOLD
MODERATE Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: Jul 30, 2026
Smart Money Accumulation
None View Scanner →
Strength: 5.8/10
Get Alerted When ILMN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: ILMN is 9.8% above its trading range ($155.65). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: ILMN is 9.8% above its trading range ($155.65). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$215.60
Based on 8.7% avg growth
INTRINSIC VALUE TODAY
$133.87
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 24.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ILMN is currently trading at $170.93, which is considered extended relative to its 30-day fair value range of $132.36 to $155.65. From a valuation perspective, the stock is trading at a premium (Forward PE: 28.9) compared to its historical average (24.1). At these levels, the market is pricing in 6.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ILMN is in a strong uptrend. The price is approaching resistance at $172.49. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.2% recently.
Market Sentiment: ILMN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $143.83. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ILMN is in a strong uptrend. The price is approaching resistance at $172.49. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.2% recently.
Market Sentiment: ILMN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $143.83. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$132.36 -
$155.65
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
51.4%
Protect Your Profits
ILMN is technically overbought (RSI 80). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+9.8% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.2%)
- BEARISH: Trading 15.9% above Wall St target ($143.83)
- NEUTRAL: Trading at premium valuation - market expects 6.2% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$132.36 -
$155.65
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$138.64
Resistance Level
$172.49
Current Trend
Strong Uptrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
28.86
Wall Street Target
$143.83
(-15.9%)
Revenue Growth (YoY)
4.8%
Earnings Growth (YoY)
6.1%
Profit Margin
19.4%
Valuation Premium vs History
+6.2% premium
PE vs Historical
28.9 vs 24.1
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.2%
(market-implied from PE analysis)
1-Year Target
$181.53
(+6%)
2-Year Target
$192.78
(+13%)
3-Year Target
$204.73
(+20%)
3-Yr Target (if PE normalizes)
(PE: 29→24)
PE COMPRESSION
$170.95
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 28.9, Growth: 13.3%)
$248.82
(+46%)
Base:
(SPY PE: 21.9, Growth: 13.3%)
$188.88
(+11%)
Bear:
(PE: 18.6, Growth: 13.3%)
$160.55
(-6%)
📈
Valuation based on Current Earnings
Trailing PE: 27.30 | Current EPS (TTM): $5.50
Bull Case
$178.10
(+12%)
Analyst growth 7.8%, PE expands to 30.0
Base Case
$161.91
(+2%)
Market implied 7.8%, PE stable at 27.3
Bear Case
$102.12
(-36%)
Severe decline -20.0%, PE contracts to 23.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: June 04, 2026 3:09 AM ET
Data refreshes hourly during market hours. Next update: 4:09 AM
Data refreshes hourly during market hours. Next update: 4:09 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ILMN showing a specific setup today?
Insider Activity (6 Months)
2
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Patricia Leckman
SELL
2370 shares
2026-02-18
Gilbert Ray Cisneros, Jr.
BUY
2026-02-10
Scott Gottlieb
BUY
200 shares
2026-02-09
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$612 | 59 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$248 | 62 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 66 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$131 | 57 HOLD |
Advanced ILMN Option Strategies
Professional options setups generated by AI based on today's ILMN price and gamma walls.
